Robert Weinberg, a prominent cancer researcher at the Whitehead Institute, issued a correction to a paper in Oncogene in May, fixing two errors missed during proofing. We found this one a little late, obviously. It also appears to be a relatively minor correction, not one that appears worthy of retraction. We’ve gotten feedback from readers … Continue reading Cancer research pioneer Robert Weinberg corrected Oncogene paper
Another domino has fallen in a chain of retractions for Robert Weinberg, the man who discovered the first tumor-causing gene in humans, along with the first tumor suppressor gene: Cancer Research just retracted a paper of his on some of the molecular steps to metastasis. The paper, “Concurrent Suppression of Integrin α5, Radixin, and RhoA Phenocopies … Continue reading Cancer Research retraction is fifth for Robert Weinberg; fourth for his former student
Robert Weinberg, a prominent cancer scientist whose papers often notch hundreds or thousands of citations, has lost a fourth paper, this time a 2009 publication in Cell. Journal Genes and Development pulled two of Weinberg’s papers in March, stating that they had retracted the 2009 study because data from several experiments was used in figures that seemed to represent … Continue reading Other shoe drops for MIT cancer researcher Robert Weinberg as Cell retraction appears
Two identical retraction notices have popped up for MIT professor Robert Weinberg, a highly-cited cancer researcher who had a retraction and a correction in 2013, both in Cancer Cell. These two new retractions, in Genes and Development, stem directly from another paper by Weinberg and colleagues in Cell that will apparently be retracted, as the “same analytical methodology was used,” … Continue reading Two more retractions appear for prominent MIT cancer researcher Robert Weinberg
Would you consider a donation to support Weekend Reads, and our daily work? The week at Retraction Watch featured: Our list of retracted or withdrawn COVID-19 papers is up past 400. There are more than 50,000 retractions in The Retraction Watch Database — which is now part of Crossref. The Retraction Watch Hijacked Journal Checker now contains more than 250 titles. And have … Continue reading Weekend reads: Retractions at Columbia; retractions for a rector; the early days of peer review
Reproducibility is everywhere recently, from the pages of scientific journals to the halls of the National Academy of Sciences, and today it lands in bookstores across the U.S. Longtime NPR correspondent Richard Harris has written Rigor Mortis (Basic Books), which is published today. (Full disclosure: I blurbed the book, writing that “Harris deftly weaves gripping tales … Continue reading “Failure is an essential part of science:” A Q&A with the author of a new book on reproducibility
A cancer researcher has added a fifth retraction to his name — but the notice doesn’t mention any problems with the paper itself. Rather, the Journal of Mammary Gland Biology and Neoplasia decided to retract the paper because it referenced other papers that had been retracted as a result of data manipulation. The notice doesn’t … Continue reading Cancer researcher logs 5th retraction
The week at Retraction Watch featured an adventure in irony as a paper on plagiarism was retracted for…plagiarism, as well as another retraction for high-profile cancer research Robert Weinberg. Here’s what was happening elsewhere:
MIT’s Robert Weinberg, a leading cancer researcher who retracted a Cancer Cell paper earlier this year for “inappropriate presentation” of figures, has corrected a different paper in the same journal. Here’s the correction for “Species- and Cell Type-Specific Requirements for Cellular Transformation:” We were apprised recently of errors made in the assembly of Figures 2B, … Continue reading A Cancer Cell mega-correction for highly cited researcher who retracted paper earlier this year
One of the world’s leading cancer researchers, MIT’s Robert Weinberg, has retracted a decade-old paper after finding out it contained errors. Here’s the notice for “Ras Modulates Myc Activity to Repress Thrombospondin-1 Expression and Increase Tumor Angiogenesis,” a paper originally published in Cancer Cell in 2003: